Phillip Dolamore
Career history of Phillip Dolamore
Former positions of Phillip Dolamore
| Companies | Position | Start | End |
|---|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Corporate Officer/Principal | 01/01/2008 | - |
Statistics
International
| United Kingdom | 3 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
| Glaxo, Inc. | |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
- Stock Market
- Insiders
- Phillip Dolamore
- Experience
